☆ 4.5 Letter

Serum IL-22 binding protein as a marker for atopic dermatitis activity and response to dupilumab treatment

CLINICAL AND EXPERIMENTAL ALLERGY (2022)

Get Full Text
Add to Collection

Journal

CLINICAL AND EXPERIMENTAL ALLERGY
Volume 52, Issue 6, Pages 820-823

Publisher

WILEY
DOI: 10.1111/cea.14147

Keywords

anti-IL-4R therapy; atopic dermatitis; IL-22; IL-22 binding protein

Categories

Allergy Immunology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.